Skip to NavigationSkip to content

News

Johnson & Johnson have announced the approval of the long-acting atypical antipsychotic therapy BYANNLI® by the European Commission (EC), for the...
The Centre for Cancer and Immunology Research, Children’s National Research Institute, have developed a new approach that identifies unique proteins...
The FDA and CDC have cleared the Pfizer and Moderna booster jabs for adults, after reviewing new data supporting the extra doses. This decision...
Obseva, a biopharmaceutical company developing and commercialising novel therapies to improve reproductive health, have announced that the NDA for...
Leading science and technology company, Merck KGaA, Darmstadt, Germany have identified five mid- to late-stage assets with first-in-class potential...
Scientists have discovered multiple factors influencing declining immunity over time with the Pfizer COVID-19 vaccine, according to News Medical.
Pfizer is seeking FDA Emergency Use Authorisation (EUA) for the novel oral antiviral, Paxlovid. The pill, if authorised, will help tackle COVID by...
Clinical-stage immunotherapy company, ImmunityBio Inc, has announced the expansion of the company’s cancer and infectious disease vaccine programmes...
NICE has recommended risdiplam as treatment for the rare genetic disorder, spinal muscular atrophy, as part of a managed access agreement (MAA). This...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches